Dual Targeted Therapy with Baricitinib and Anifrolumab in Infantile Spondyloenchondrodysplasia with Immune Dysregulation

by
Spread the love

J Clin Immunol. 2025 Nov 8;45(1):155. doi: 10.1007/s10875-025-01954-3.

NO ABSTRACT

PMID:41203937 | DOI:10.1007/s10875-025-01954-3

Leave a Comment

Error: Connection timed out (110)